-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on CG Oncology, Lowers Price Target to $89

Benzinga·11/09/2026 15:41:21
Listen to the news
Guggenheim analyst Michael Schmitz maintains CG Oncology (NASDAQ:CGON) with a Buy and lowers the price target from $90 to $89.